Our bench strength is in our extensive experience and team approach. We strive to facilitate each of our client’s needs through strategy, research, and collaboration.
Dr. Kay is the co-founder of Cognitive Research Corporation and currently serves as Chief Scientific Officer. He received his Ph.D. in psychology (neuro-clinical specialty program) from the University of Memphis and completed his psychology internship at the National Naval Medical Center in Bethesda, Maryland.
From 1985 to 1998, Dr. Kay served as Director of the Neuropsychology Division at Georgetown University School of Medicine’s Department of Neurology. He took an active role in teaching, providing clinical services, and conducting research. Notably, his research included efforts to assess higher cortical functions via computerized methods and conducting investigations into the neuropsychological sequelae of HIV infection, head injury, fibromyalgia, diabetes, eosinophilia myalgia syndrome, alcoholism, and normal aging. He is the author and publisher of CogScreen, a computerized cognitive test battery used in pharmaceutical research and in clinical practice. He is recognized globally as an expert in the use of driving simulation to assess the impact of drugs on driving performance.
Dr. Kay established the Washington Neuropsychological Institute in 1998. The firm conducted contract research and provided consultation to federal agencies such as the Federal Aviation Administration, the Department of Justice, and the Social Security Administration.
Dr. Kay served as Principal Investigator on single and multi-center clinical drug trials investigating the effects of medication on cognition, mood, and psychomotor performance. He played a key role in studies investigating changes in cognition associated with sedating antihistamines, hormone replacement therapy, stimulant medications, anticholinergics, and nutritional supplements.
Dr. Kay has been invited to speak at professional meetings around the world and has been a speaker and author for the National Academy of Sciences. He has testified before U.S. congressional committees, at FDA hearings, and has served as a consultant for numerous governmental, corporate, and medical organizations. He is the co-author of Aeromedical Psychology, has written several book chapters, and authored numerous peer-reviewed articles that have appeared in Archives of Internal Medicine, American Psychologist, Human Psychopharmacology, British Journal of Pharmacology, Aviation Space and Environmental Medicine, Annals of Allergy, and the American Journal of Managed Care.
Dr. Kay is a diplomate of the American Board of Professional Neuropsychology and the American Board of Assessment Psychology. He is an Associate Professor of Neurology at Georgetown University, a Fellow of the National Academy of Neuropsychologists, and a member of both the International Neuropsychological Society and the American Psychological Association.